India's Hikal falls after unit gets 6 observations from USFDA

Hikal

10/02/2025 05:51

** Shares of pharmaceuticals company Hikal  HIKA.NS  fall 5.1%
to 357.55 rupees
** Co says US Food and Drug Administration (USFDA) concludes
inspection at Jigani unit in Bengaluru with six observations
    ** Co did not specify what the observations are
    ** Trading vol at 249,574 shares, compared to 30-day avg of
265,596 shares
    ** Stock extends YTD losses to 8.4%

(Reporting by Meenakshi Maidas in Bengaluru)
((meenakshi.maidas@thomsonreuters.com;))